Author:
Cao Lu,Yang Tongfei,Hou Yajing,Yong Suyun,Zhou Nan
Funder
Shaanxi Provincial People's Hospital Science and Technology Development Incubation Funding
Pharmaceutical Services Research Fund of Shaanxi Health Care Association
Shaanxi Pharmaceutical Association Hospital pharmacy high-quality development research project
Publisher
Springer Science and Business Media LLC
Reference125 articles.
1. Mansour NO, Boraii S, Elnaem MH, et al. Evaluation of preoperative duloxetine use for postoperative analgesia following laparoscopic cholecystectomy: a randomized controlled trial. Front Pharmacol. 2022;13: 944392.
2. Wu S, Chen Z, Liu R, et al. SurgSmart: an artificial intelligent system for quality control in laparoscopic cholecystectomy: an observational study. Int J Surg. 2023;109:1105–14.
3. Gupta A, Singh A, Ranjan P. role of pre-emptive tapentadol in reduction of postoperative analgesic requirements after laparoscopic cholecystectomy. Int J Acad Med Pharm. 2023;5:1631–6.
4. Gurusamy KS, Vaughan J, Toon CD, Davidson BR. Pharmacological interventions for prevention or treatment of postoperative pain in people undergoing laparoscopic cholecystectomy. Cochrane Database Syst Rev. 2014;28:CD008261.
5. Jain S, Nazir N, Mustafi SM. Preemptive low-dose intravenous ketamine in the management of acute and chronic postoperative pain following laparoscopic cholecystectomy: a prospective randomized control study. Med Gas Res. 2022;12:141–5.